Materials And Products Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Edoxaban (B01af03) as Part of a So-Called Open House Model.

Open House Drug Discount Agreements Eltrombopag, Atc B02bx05

Open House Drug Discount Agreements Infliximab, Atc L04ab02

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Timolol + Brinzolamide, Atc S01ed67 (Obg) for the Period November 1St, 2024 - October 31St, 2026

Open House Drug Discount Agreements Lopinavir and Ritonavir, Atc J05ar10

Open House Drug Discount Agreements Naproxen, Atc M01ae02

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Clobetasol (D07ad01) as Part of a So-Called Open House Model.

A60, Thorough Road Renewal between the Ruesselsheimer Triangle and the Mainspitzdreieck (Km 3.0 - Km 10.0, Direction Mainz)

Market Exploration Software Menu Ordering System

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Dasatinib (Excl. Potency 100 Mg in the Standard Size N2 and N3, Atc L01ea02 F. D. Z. 01.11.24 - 31.10.26